AI Article Synopsis
- The document discusses five cases of envenomation and complications from saw scaled viper bites in Karnataka over five years (Dec 2019-May 2023).
- Despite being a smaller member of the "Big Four" venomous snakes, its bites can lead to serious health issues, including persistent coagulopathy and anaphylaxis in some patients.
- The findings highlight that the current Indian polyvalent antivenom (ASV) may not be consistently effective and suggest necessary updates to treatment protocols for snake bites.
Article Abstract
We describe 5 cases of envenomation and complications related to saw scaled viper () bites from the Western Ghats region of Karnataka over a period of 5 years (December 2019-May 2023). Although the smallest member of the Big Four, Saw Scaled viper envenomation is associated with significant morbidity. In our region, envenomation appears to be rare. The careful review of all these cases has suggested VICC with one patient having persistent coagulopathy despite adequate ASV administration, and three patients developing anaphylaxis. It needs to be brought to notice that the complications due to envenoming run high, despite timely administration of ASV. Through these cases, we want to contribute evidence suggesting variable efficacy of Indian polyvalent ASV for bites and the need for updating protocols for the same.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11408150 | PMC |
| http://dx.doi.org/10.1016/j.toxrep.2024.101721 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!